Pharmacotherapy for uveitis: current management and emerging therapy
Robert J Barry,1 Quan Dong Nguyen,2 Richard W Lee,3 Philip I Murray,1 Alastair K Denniston1,4 1Academic Unit of Ophthalmology, Centre for Translational Inflammation, Research, University of Birmingham, UK; 2Stanley M Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, NE, USA; 3I...
Main Authors: | Barry RJ, Nguyen QD, Lee RW, Murray PI, Denniston AK |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-09-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/pharmacotherapy-for-uveitis-current-management-and-emerging-therapy-peer-reviewed-article-OPTH |
Similar Items
-
mTOR-inhibiting pharmacotherapy for the treatment of non-infectious uveitis: a systematic review protocol
by: Joshua Blair, et al.
Published: (2018-06-01) -
An update on the use of biologic therapies in the management of uveitis in Behçet’s disease: a comprehensive review
by: Thomas W. McNally, et al.
Published: (2017-07-01) -
Current and Emerging Pharmacotherapy for Fibromyalgia
by: Roie Tzadok, et al.
Published: (2020-01-01) -
Current and Emerging Pharmacotherapies for Primary CNS Lymphoma
by: Prathima Prodduturi Md, et al.
Published: (2012-01-01) -
Current and Emerging Pharmacotherapies for Primary CNS Lymphoma
by: Prathima Prodduturi, et al.
Published: (2012-05-01)